New research published today shows that almost half (45.6%) of Australian teens are living with chronic diseases or developmental conditions like attention deficit hyperactivity disorder (ADHD) or autism (ASD). The study ...
Apr 4, 2025
0
0
Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for renal regenerative therapies ...
Apr 3, 2025
0
0
A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.
Apr 3, 2025
0
1
Earlier this year, the U.S. Food and Drug Administration (FDA) proposed a new rule to limit nicotine in cigarettes and certain other tobacco products, like cigars and pipe tobacco, bringing nicotine down to minimal or nonaddictive ...
Apr 1, 2025
0
0
Research led by Children's Hospital of Fudan University in China has found that a gene called pancreatic progenitor cell differentiation and proliferation factor (PPDPF) helps protect kidney cells by supporting enzymes involved ...
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical ...
Mar 31, 2025
0
3
A new consensus paper provides an updated evaluation of reference bone turnover markers (BTMs) and newer markers in the diagnosis and management of osteoporosis.
Mar 31, 2025
0
0
For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed.
Mar 31, 2025
0
0
Patients with narrowing of at least 50% in three major coronary arteries did equally well when treated with a minimally invasive stent placement guided either by ultrasound-based imaging or by a novel, artificial-intelligence-powered ...
Mar 31, 2025
0
16
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.
Mar 31, 2025
0
32
